A Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs Immune globulin (Primary) ; Albumins
  • Indications Diabetic neuropathies; Neurogenic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.
    • 17 May 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.
    • 12 Apr 2017 Status changed from recruiting to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top